| Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ... Pain 160 (1), 136-150, 2019 | 417 | 2019 |
| Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery T Atkin, S Comai, G Gobbi, EL Barker Pharmacological reviews 70 (2), 197-245, 2018 | 394 | 2018 |
| Epilepsy, antiepileptic drugs, and aggression: an evidence-based review MJ Brodie, F Besag, AB Ettinger, M Mula, G Gobbi, S Comai, ... Pharmacological reviews 68 (3), 563-602, 2016 | 321 | 2016 |
| The content of proteic and nonproteic (free and protein-bound) tryptophan in quinoa and cereal flours S Comai, A Bertazzo, L Bailoni, M Zancato, CVL Costa, G Allegri Food Chemistry 100 (4), 1350-1355, 2007 | 303 | 2007 |
| Tryptophan in health and disease S Comai, A Bertazzo, M Brughera, S Crotti Advances in clinical chemistry 95, 165-218, 2020 | 260 | 2020 |
| CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology S Comai, G Gobbi Journal of Psychiatry and Neuroscience 39 (1), 6-21, 2014 | 226 | 2014 |
| The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology S Comai, M Tau, G Gobbi Journal of clinical psychopharmacology 32 (1), 83-94, 2012 | 173 | 2012 |
| d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology D De Gregorio, S Comai, L Posa, G Gobbi International journal of molecular sciences 17 (11), 1953, 2016 | 155 | 2016 |
| The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium S Comai, M Tau, Z Pavlovic, G Gobbi Journal of clinical psychopharmacology 32 (2), 237-260, 2012 | 155 | 2012 |
| Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand R Ochoa-Sanchez, S Comai, B Lacoste, FR Bambico, ... Journal of Neuroscience 31 (50), 18439-18452, 2011 | 155 | 2011 |
| Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep G Gobbi, S Comai Frontiers in endocrinology 10, 87, 2019 | 152 | 2019 |
| Monoamine oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder D Checknita, G Maussion, B Labonté, S Comai, RE Tremblay, F Vitaro, ... The British Journal of Psychiatry 206 (3), 216-222, 2015 | 145 | 2015 |
| Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice S Comai, R Ochoa-Sanchez, G Gobbi Behavioural brain research 243, 231-238, 2013 | 135 | 2013 |
| The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors D De Gregorio, L Posa, R Ochoa-Sanchez, R McLaughlin, S Maione, ... Pharmacological Research 113, 81-91, 2016 | 105 | 2016 |
| Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways M Lopez-Canul, E Palazzo, S Dominguez-Lopez, L Luongo, B Lacoste, ... Pain 156 (2), 305-317, 2015 | 101 | 2015 |
| The content of protein and non-protein (free and protein-bound) tryptophan in Theobroma cacao beans A Bertazzo, S Comai, I Brunato, M Zancato, CVL Costa FOOD chemistry 124 (1), 93-96, 2011 | 98 | 2011 |
| Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission D De Gregorio, J Popic, JP Enns, A Inserra, A Skalecka, A Markopoulos, ... Proceedings of the National Academy of Sciences 118 (5), e2020705118, 2021 | 97 | 2021 |
| Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide A Messaoud, R Mensi, W Douki, F Neffati, MF Najjar, G Gobbi, F Valtorta, ... The World Journal of Biological Psychiatry, 2019 | 93 | 2019 |
| Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam R Ochoa-Sanchez, Q Rainer, S Comai, G Spadoni, A Bedini, S Rivara, ... Progress in neuro-psychopharmacology and biological psychiatry 39 (2), 318-325, 2012 | 92 | 2012 |
| Serotonin dysfunction, aggressive behavior, and mental illness: exploring the link using a dimensional approach M Manchia, B Carpiniello, F Valtorta, S Comai ACS chemical neuroscience 8 (5), 961-972, 2017 | 89 | 2017 |
